{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:16:28Z","timestamp":1777392988915,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2790,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.ijid.2005.06.001","type":"journal-article","created":{"date-parts":[[2005,11,12]],"date-time":"2005-11-12T12:11:11Z","timestamp":1131797471000},"page":"25-31","source":"Crossref","is-referenced-by-count":37,"title":["Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei"],"prefix":"10.1016","volume":"10","author":[{"given":"Steven P.","family":"LaRosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Opal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Utterback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sau Chi Betty","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Helterbrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.H.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wipada","family":"Chaowagul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles J.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2005.06.001_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/clinids\/11.3.413","article-title":"Melioidosis: review and update","volume":"11","author":"Leelarasamee","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0035-9203(88)90249-0","article-title":"Clinical and laboratory studies of malaria and melioidosis","volume":"82","author":"White","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2005.06.001_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/AAC.36.1.158","article-title":"Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis","volume":"36","author":"Sookpranee","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2005.06.001_bib4","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/infdis\/159.5.890","article-title":"Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand","volume":"159","author":"Chaowagul","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1099\/0022-1317-50-8-657","article-title":"Melioidosis: a clinical model for Gram-negative sepsis","volume":"50","author":"Simpson","year":"2001","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijid.2005.06.001_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V72.1.128.bloodjournal721128","article-title":"Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U 937 and peripheral blood monocytes","volume":"72","author":"Conkling","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2005.06.001_bib7","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1055\/s-0038-1650653","article-title":"Interleukin-6 stimulates coagulation, not fibrinolysis, in humans","volume":"76","author":"Stouthard","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijid.2005.06.001_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/315306","article-title":"Differential antibiotic-induced endotoxin release in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1086\/315271","article-title":"Prognostic value of cytokine concentrations (tumor necrosis factor-\u03b1, interleukin-6 and interleukin-10) and clinical parameters in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0037-1615840","article-title":"Endothelial protein C receptor","volume":"82","author":"Esmon","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijid.2005.06.001_bib11","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1182\/blood.V68.6.1218.1218","article-title":"Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor","volume":"68","author":"Sakata","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2005.06.001_bib12","first-page":"A266","article-title":"Activated protein C reduces ischemia\/reperfusion induced acute renal injury by inhibiting leukocyte activation in rats","volume":"91","author":"Mizutani","year":"1999","journal-title":"Anesthesiology"},{"issue":"pt 1","key":"10.1016\/j.ijid.2005.06.001_bib13","first-page":"L197","article-title":"Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production","volume":"272","author":"Murakami","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ijid.2005.06.001_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/glycob\/4.2.221","article-title":"Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide","volume":"4","author":"Grinnell","year":"1994","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijid.2005.06.001_bib15","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/0002-9343(89)80523-6","article-title":"Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism","volume":"87","author":"Rosenberg","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2005.06.001_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1055\/s-2007-996140","article-title":"Antithrombin (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III","volume":"23","author":"Uchiba","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.ijid.2005.06.001_bib17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02171862","article-title":"Recombinant human protein C, protein S and thrombomodulin as antithrombotics","volume":"1","author":"Yan","year":"1994","journal-title":"Perspect Drug Discov Des"},{"key":"10.1016\/j.ijid.2005.06.001_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-995821","article-title":"Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock","volume":"24","author":"Vervloet","year":"1998","journal-title":"Semin Thromb Haemost"},{"key":"10.1016\/j.ijid.2005.06.001_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/520219","article-title":"Comparison of imipenem and ceftazidime as therapy for severe melioidosis","volume":"29","author":"Simpson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib20","first-page":"637","article-title":"Acute systemic melioidosis: an autopsy of six cases","volume":"19","author":"Atisook","year":"1988","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.ijid.2005.06.001_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-199907000-00017","article-title":"Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-\u03b1","volume":"27","author":"Martinez","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2005.06.001_bib22","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1378\/chest.103.5.1536","article-title":"Time course of hemostatic abnormalities in sepsis and its relation to outcome","volume":"103","author":"Lorente","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2005.06.001_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1378\/chest.101.3.816","article-title":"Septic shock, multiple organ failure and disseminated intravascular coagulation: compared patterns of antithrombin, protein C and protein S deficiencies","volume":"101","author":"Fourrier","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2005.06.001_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ajh.2830410106","article-title":"Protein C survival during replacement therapy in homozygous protein C deficiency","volume":"41","author":"Marlar","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijid.2005.06.001_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF01709832","article-title":"Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases","volume":"18","author":"Leclerc","year":"1992","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijid.2005.06.001_bib26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0049-3848(89)90054-6","article-title":"The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease","volume":"55","author":"Brandtzaeg","year":"1989","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijid.2005.06.001_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0038-1651669","article-title":"Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality","volume":"73","author":"Fijnvandraat","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijid.2005.06.001_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/375593","article-title":"Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)","volume":"37","author":"Opal","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2005.06.001_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00003246-198908000-00002","article-title":"Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome","volume":"17","author":"Hesselvik","year":"1989","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2005.06.001_bib30","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2005.06.001_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"New Engl J Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971205001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T20:26:39Z","timestamp":1586550399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971205001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1201971205001402"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2005.06.001","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}